Literature DB >> 32888319

Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor.

Héctor de Lucio1, Miguel A Toro2, María-José Camarasa3, Sonsoles Velázquez3, Federico Gago4, Antonio Jiménez-Ruiz1.   

Abstract

BACKGROUND AND
PURPOSE: Peptide P4 was described as a dimerization disruptor of trypanothione reductase (TryR), a homodimeric enzyme essential for survival of trypanosomatids. Determination of the true inhibitory constant (Ki ) for P4 was not achieved because reaction rates continuously decreased with time, even when substrate concentration was kept constant. The aim of this study was to find a suitable kinetic model that could allow characterization of the complex pattern of TryR inhibition caused by P4. EXPERIMENTAL APPROACH: After showing the slow-binding and pseudoirreversible activity of P4 against Leishmania infantum trypanothione reductase (Li-TryR), analysis of the curvatures of the reaction progress curves at different inhibitor concentrations allowed us to define the apparent inhibitory constants (Ki app ) at five different substrate concentrations. Analysis of the changes in Ki app values allowed precise definition of the type of inhibition. KEY
RESULTS: Li-TryR inhibition by P4 requires two sequential steps that involve rapid generation of a reversible enzyme-inhibitor complex followed by a pseudoirreversible slow inactivation of the enzyme. Recovery of enzyme activity after inhibitor dissociation is barely detectable. P4 is a non-competitive pseudoirreversible inhibitor of Li- TryR that displays an overall inhibition constant (Ki * ) smaller than 0.02 μM. CONCLUSION AND IMPLICATIONS: Li-TryRdimer disruption by peptide P4 is a pseudoirreversible time-dependent process which is non-competitive with respect to the oxidized trypanothione (TS2 ) substrate. Therefore, unlike reversible Li-TryR competitive inhibitors, enzyme inhibition by P4 is not affected by the TS2 accumulation observed during oxidant processes such as the oxidative burst in host macrophages.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  Leishmania infantum; dimerization disruptor; protein-protein interactions; pseudoirreversible inhibition; slow-binding inhibitor; time-dependent inhibition; trypanothione reductase

Mesh:

Substances:

Year:  2020        PMID: 32888319      PMCID: PMC7588817          DOI: 10.1111/bph.15250

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

Review 1.  Drug-target residence time and its implications for lead optimization.

Authors:  Robert A Copeland; David L Pompliano; Thomas D Meek
Journal:  Nat Rev Drug Discov       Date:  2006-08-04       Impact factor: 84.694

2.  Specificity of the trypanothione-dependent Leishmania major glyoxalase I: structure and biochemical comparison with the human enzyme.

Authors:  Antonio Ariza; Tim J Vickers; Neil Greig; Kirsten A Armour; Mark J Dixon; Ian M Eggleston; Alan H Fairlamb; Charles S Bond
Journal:  Mol Microbiol       Date:  2006-02       Impact factor: 3.501

3.  Probing the dimerization interface of Leishmania infantum trypanothione reductase with site-directed mutagenesis and short peptides.

Authors:  Miguel A Toro; Pedro A Sánchez-Murcia; David Moreno; Marta Ruiz-Santaquiteria; Juan Fernando Alzate; Ana Negri; María-José Camarasa; Federico Gago; Sonsoles Velázquez; Antonio Jiménez-Ruiz
Journal:  Chembiochem       Date:  2013-06-06       Impact factor: 3.164

Review 4.  Leishmania infections: Molecular targets and diagnosis.

Authors:  Mohammad Akhoundi; Tim Downing; Jan Votýpka; Katrin Kuhls; Julius Lukeš; Arnaud Cannet; Christophe Ravel; Pierre Marty; Pascal Delaunay; Mohamed Kasbari; Bruno Granouillac; Luigi Gradoni; Denis Sereno
Journal:  Mol Aspects Med       Date:  2017-01-31

5.  Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase.

Authors:  Chris J Hamilton; Ahilan Saravanamuthu; Ian M Eggleston; Alan H Fairlamb
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

6.  Ovothiol and trypanothione as antioxidants in trypanosomatids.

Authors:  M R Ariyanayagam; A H Fairlamb
Journal:  Mol Biochem Parasitol       Date:  2001-07       Impact factor: 1.759

7.  Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus.

Authors:  J Tovar; S Wilkinson; J C Mottram; A H Fairlamb
Journal:  Mol Microbiol       Date:  1998-07       Impact factor: 3.501

8.  Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

Authors:  W X Tian; C L Tsou
Journal:  Biochemistry       Date:  1982-03-02       Impact factor: 3.162

Review 9.  Metabolism and functions of trypanothione in the Kinetoplastida.

Authors:  A H Fairlamb; A Cerami
Journal:  Annu Rev Microbiol       Date:  1992       Impact factor: 15.500

Review 10.  A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies.

Authors:  Mohammad Akhoundi; Katrin Kuhls; Arnaud Cannet; Jan Votýpka; Pierre Marty; Pascal Delaunay; Denis Sereno
Journal:  PLoS Negl Trop Dis       Date:  2016-03-03
View more
  3 in total

1.  Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor.

Authors:  Héctor de Lucio; Miguel A Toro; María-José Camarasa; Sonsoles Velázquez; Federico Gago; Antonio Jiménez-Ruiz
Journal:  Br J Pharmacol       Date:  2020-10-02       Impact factor: 8.739

2.  Probing the Interactions Responsible for the Structural Stability of Trypanothione Reductase Through Computer Simulation and Biophysical Characterization.

Authors:  Anurag Kumar; Prajakta Nimsarkar; Shailza Singh
Journal:  Protein J       Date:  2022-04-02       Impact factor: 2.371

3.  Druggable hot spots in trypanothione reductase: novel insights and opportunities for drug discovery revealed by DRUGpy.

Authors:  Olivia Teixeira; Pedro Lacerda; Thamires Quadros Froes; Maria Cristina Nonato; Marcelo Santos Castilho
Journal:  J Comput Aided Mol Des       Date:  2021-06-28       Impact factor: 3.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.